Device Trial Radar · NCT03590899
Semi-manual Vessel Density Analysis on Optical Coherence Tomography Angiography Images of Healthy Adults
Last checked: Nov 19, 2026Latest source record: Jun 30, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
39
Actual
Start
Feb 1, 2017
Primary completion
Nov 20, 2018
Study completion Mar 30, 2022
Sponsor
- Lead sponsor
- Semmelweis UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 18, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Purpose of the study is to examine the vessel density of healthy adults' optical coherence tomography angiography images with two semi-manual methods and an automated quantification program.
Conditions
- Healthy
Interventions
Optical coherence tomography angiography (Zeiss Cirrus HD OCT 5000 AngioPlex)Device
Non-invasive, non-contact optical coherence tomography angiography scans of the retina are done per built-in device protocol using the Zeiss Cirrus HD OCT 5000 AngioPlex machine.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Vessel density (VD) measured by Mexican Hat filtering techniqueTime frame: Through study completion, 1 year
- Skeleton density (SD) measured by Mexican Hat filtering techniqueTime frame: Through study completion, 1 year
- Vessel diameter index (VDI) measured by Mexican Hat filtering techniqueTime frame: Through study completion, 1 year
5 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Semmelweis University, Department of Ophthalmology
Budapest, Hungary
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.